This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
TRAF2/3 deficient B cells resist DNA damage-induced apoptosis via NF-κB2/XIAP/cIAP2 axis and IAP antagonist sensitizes mutant lymphomas to chemotherapeutic drugs
Cell Death & Disease Open Access 08 September 2023
-
TGFβ-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosis
Nature Communications Open Access 26 June 2019
-
Mutated in colorectal cancer (MCC) is a novel oncogene in B lymphocytes
Journal of Hematology & Oncology Open Access 09 September 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pospisilova H, Baens M, Michaux L, Stul M, Van Hummelen P, Van Loo P et al. Interstitial del(14)(q) involving IGH: a novel recurrent aberration in B-NHL. Leukemia 2007; 21: 2079–2083.
Tilly H, Bastard C, Halkin E, Lenormand B, Bizet M, Dauce JP et al. Del(14)(q22) in diffuse B-cell lymphocytic lymphoma. Am J Clin Pathol 1988; 89: 109–113.
Annunziata CM, Davis RE, Demchenko Y, Bellamy W, Gabrea A, Zhan F et al. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 2007; 12: 115–130.
Keats JJ, Fonseca R, Chesi M, Schop R, Baker A, Chng WJ et al. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 2007; 12: 131–144.
Braggio E, Keats JJ, Leleu X, Van Wier S, Jimenez-Zepeda VH, Valdez R et al. Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom′s macroglobulinemia. Cancer Res 2009; 69: 3579–3588.
Xie P, Stunz LL, Larison KD, Yang B, Bishop GA . Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs. Immunity 2007; 27: 253–267.
He JQ, Saha SK, Kang JR, Zarnegar B, Cheng G . Specificity of TRAF3 in its negative regulation of the noncanonical NF-kappa B pathway. J Biol Chem 2007; 282: 3688–3694.
Basseres DS, Baldwin AS . Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 2006; 25: 6817–6830.
Acknowledgements
We gratefully thank Kerstin Runde, Reina Zühlke-Jenisch, Magret Ratjen, Dorit Schuster, Claudia Becher and Ursula Schnaidt for their technical assistance. Supported by the Network Project of the Deutsche Krebshilfe ‘Molecular Mechanisms in Malignant Lymphomas’ 70-3173-TR3, the Wilhelm Sander-Stiftung 2005.168.2 and RETICS. Instituto de Salud Carlos III, RETICS. Convocatoria 2008. RD07/0020/2004.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)
Rights and permissions
About this article
Cite this article
Nagel, I., Bug, S., Tönnies, H. et al. Biallelic inactivation of TRAF3 in a subset of B-cell lymphomas with interstitial del(14)(q24.1q32.33). Leukemia 23, 2153–2155 (2009). https://doi.org/10.1038/leu.2009.149
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2009.149
This article is cited by
-
TRAF2/3 deficient B cells resist DNA damage-induced apoptosis via NF-κB2/XIAP/cIAP2 axis and IAP antagonist sensitizes mutant lymphomas to chemotherapeutic drugs
Cell Death & Disease (2023)
-
Structural feature of TRAFs, their related human diseases and therapeutic intervention
Archives of Pharmacal Research (2021)
-
TGFβ-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosis
Nature Communications (2019)
-
Mutated in colorectal cancer (MCC) is a novel oncogene in B lymphocytes
Journal of Hematology & Oncology (2014)
-
N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma
BMC Cancer (2013)